© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Chemical Name: Imiquimod
Common Uses: Topical cream for skin conditions such as genital warts, actinic keratosis, and superficial basal cell carcinoma
Physical Appearance: White to off-white crystalline powder, typically supplied in single-use packets as a cream
Main Users: Healthcare workers, patients under prescription guidance
Routes of Exposure: Skin contact, accidental ingestion, inhalation of dust (rare in finished formulations)
Potential Health Effects: Skin irritation, redness, swelling, risk of allergic reactions, rare reports of systemic symptoms including fatigue and flu-like effects after topical use
Signal Word: Warning
Acute Risks: Severe itching, burning sensation at application site; rare chance of hypersensitivity
Chronic Risks: No strong evidence links topical use to chronic systemic toxicity, but repeated or misuse increases risk of prolonged dermatitis
Environmental Risks: Possible aquatic harm if released in large quantities
Active Ingredient: Imiquimod
Chemical Structure: 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine
Concentration: Cream usually contains 5% Imiquimod by weight
Inactive Components: Isostearic acid, benzyl alcohol, polysorbate 60, sorbitan monostearate, cetyl alcohol, stearyl alcohol, white petrolatum, water
Skin Contact: Remove contaminated clothing; wash skin thoroughly with mild soap and water; seek medical advice if irritation continues
Eye Contact: Rinse cautiously with water for several minutes; visit an eye specialist if symptoms persist
Ingestion: Rinse mouth, do not induce vomiting; consult poison control or a healthcare provider
Inhalation: Move to fresh air; monitor for breathing difficulty or cough; get medical attention if distress occurs
Suitable Extinguishing Agents: Use foam, dry chemical, or carbon dioxide for local fires
Special Hazards: Potential for toxic fumes including nitrogen oxides and carbon monoxide if heated to high temperatures
Protective Equipment: Wear self-contained breathing apparatus and full protective gear
Fire-Fighting Procedures: Avoid direct contact with the substance and run-off; cool container with water spray from a safe distance
Personal Precautions: Gloves, eye protection, long sleeves recommended
Containment: Prevent further leakage or spillage if safe; avoid drug residue entering drains or open water
Cleanup Method: Collect spilled material with absorbent; wash area thoroughly; dispose of cleanup materials following medical waste guidelines
Handling Guidelines: Limit direct contact; apply only as prescribed; avoid inhaling powders or aerosols during compounding
Storage Conditions: Room temperature 20-25°C; protect from heat, light, and moisture; store out of children’s reach
Specific Recommendations: Secure unused or expired packets to prevent accidental use or environmental release
Engineering Controls: Good room ventilation in compounding or healthcare settings
Personal Protection: Disposable nitrile gloves, lab coat, safety glasses when handling bulk ingredient or during manufacturing
Hygiene Measures: Wash hands thoroughly after exposure; avoid eating or drinking near workspaces
Workplace Monitoring: Not typically monitored in healthcare settings, but should be considered in pharmaceutical manufacturing
Appearance: White to faintly yellow crystalline powder; cream formulation is white and smooth
Odor: None to faint chemical odor
Solubility: Poorly soluble in water; soluble in organic solvents
Melting Point: 295°C (decomposes)
pH (Cream): Around 4.5
Boiling Point: Data not readily available, decomposes before boiling
Chemical Stability: Stable under regular conditions of use and storage
Reactivity: Inert with common materials, but avoid strong oxidizers
Decomposition Products: Carbon oxides, nitrogen oxides during burning or intense heating
Incompatibilities: Strong acids, bases, or oxidizing agents tend to degrade the molecule
Estimated Toxicity: Low acute oral toxicity; application data in humans shows mild to moderate reactions at skin application sites
Carcinogenic Status: Not classified as carcinogenic by major agencies
Systemic Effects: Large intentional ingestion could give rise to nausea, headache, or flu-like symptoms; topical exposure mainly brings local irritation
Allergic Reactions: Rare, but cases of severe hypersensitivity in sensitive individuals have been reported
Aquatic Impact: Imiquimod shows potential for toxicity in aquatic environments in concentrated or bulk quantities; not persistent under most environmental conditions
Biodegradability: Limited data, but it does not readily break down in water
Mobility: Low mobility due to insolubility in water
Unused Product and Waste: Treat as pharmaceutical waste; use authorized incineration where possible
Packaging: Dispose of according to local regulations on contaminated medical packaging
Small Quantities: Small amounts may be disposed of in regular medical sharps or pharmaceutical collection sites
Land Transport: Not considered dangerous for ground shipping in prescribed amounts
Air and Sea Transport: No special transport regulation for finished products
Bulk Quantities: If shipping raw compound, label as pharmaceutical ingredient with appropriate risk statements
Packing Group: Not assigned
Environmental Hazards During Transit: Risk minimized in sealed containers; avoid temperature extremes
Status in Healthcare: Prescription-only medicine in most countries
Workplace Regulations: Usually falls under occupational exposure guidelines for pharmaceutical agents
Environmental Rules: Encouraged waste minimization; environmental discharge discouraged
Labeling: Strict labeling standards for finished medications; healthcare providers must follow national and local requirements
